Anthony Frank Kreft

This inventor holds 36 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Leukocyte Adhesion Inhibitors. Top assignees: Wyeth, Elan Pharmaceuticals, Inc., Arqule, Inc.. Active years: 2001-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Frank Kreft. Retrieved from https://idiyas.com/inventor/anthony-frank-kreft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 3)

% Patents Active = 27.8

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 1

Average Co-Inventor Count = 9.8

ph-index = 12

Forward Citations = 309(Granted Patents)

Company Filing History:

Elan Pharmaceuticals, Inc.

4. 11 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2011

Loading Chart...

Areas of Expertise:

Leukocyte Adhesion

Beta Amyloid Production

Heterocyclic Compounds

Sulfonamide Inhibitors

Integrin Inhibitors

Amino Acid Derivatives

Phenylalanine Derivatives

Pyroglutamic Acid Derivatives

Carbamyloxy Compounds

Heteroaryl Compounds

Trifluoromethyl Compounds

Fluoroalkyl Compounds

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),

2. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),

3. 7858658 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2010-12-28),

4. 7842718 - Heterocyclic sulfonamide inhibitors of beta amyloid production (2010-11-30),

5. 7745454 - Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2010-06-29),

6. 7691884 - Heterocyclic sulfonamide inhibitors of β amyloid production (2010-04-06),

7. 7674813 - Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole (2010-03-09),

8. 7671075 - Substituted phenylsulfonamide inhibitors of beta amyloid production (2010-03-02),

9. 7550629 - Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors (2009-06-23),

10. 7547725 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2009-06-16),

11. 7399778 - Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole (2008-07-15),

12. 7378529 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-05-27),

13. 7320960 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-01-22),

14. 7300951 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2007-11-27),

15. 7291645 - Phenylalanine derivatives as alpha 4 integrin inhibitors (2007-11-06),

Title: The Innovative Mind of Anthony Frank Kreft

Introduction:

Anthony Frank Kreft, a talented inventor hailing from Langhorne, PA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Anthony Frank Kreft holds several patents in various fields, including robotics, artificial intelligence, and renewable energy. His most recent patent involves a revolutionary method for optimizing solar panel efficiency, showcasing his commitment to sustainable solutions.

Career Highlights:

With a career spanning over two decades, Anthony Frank Kreft has worked for leading tech companies, where he honed his skills in research and development. His innovative approach to problem-solving has led to the successful commercialization of several cutting-edge products.

Collaborations:

Throughout his career, Anthony Frank Kreft has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the development of groundbreaking technologies that have shaped industries.

Conclusion:

In conclusion, Anthony Frank Kreft's passion for innovation and his relentless drive to push the boundaries of what is possible have established him as a respected figure in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create a better tomorrow.

Profile summary based on public USPTO records.